USD 0.8
(7.44%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.71 Million USD | -23.18% |
2022 | 3.54 Million USD | -37.5% |
2021 | 5.66 Million USD | -26.84% |
2020 | 7.74 Million USD | -40.73% |
2019 | 13.06 Million USD | 272.99% |
2018 | 3.5 Million USD | -62.02% |
2017 | 9.22 Million USD | 80.15% |
2016 | 5.11 Million USD | 1224.53% |
2015 | 386.45 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 387.09 Thousand USD | -1.13% |
2024 Q2 | 553.47 Thousand USD | 42.98% |
2023 Q4 | 391.53 Thousand USD | -64.32% |
2023 Q3 | 1.09 Million USD | 109.59% |
2023 Q2 | 523.53 Thousand USD | -26.04% |
2023 Q1 | 707.87 Thousand USD | 4.74% |
2022 Q4 | 675.82 Thousand USD | -18.84% |
2022 Q2 | 932.23 Thousand USD | -15.21% |
2022 FY | 3.54 Million USD | -37.5% |
2022 Q1 | 1.09 Million USD | -25.69% |
2022 Q3 | 832.71 Thousand USD | -10.68% |
2021 Q2 | 1.6 Million USD | 33.67% |
2021 Q3 | 1.37 Million USD | -14.19% |
2021 Q4 | 1.47 Million USD | 7.38% |
2021 FY | 5.66 Million USD | -26.84% |
2021 Q1 | 1.2 Million USD | 290.79% |
2020 Q2 | 3.35 Million USD | 133.17% |
2020 FY | 7.74 Million USD | -40.73% |
2020 Q4 | -629.64 Thousand USD | -117.62% |
2020 Q3 | 3.57 Million USD | 6.42% |
2020 Q1 | 1.44 Million USD | -20.87% |
2019 Q4 | 1.82 Million USD | 14.98% |
2019 FY | 13.06 Million USD | 272.99% |
2019 Q1 | 6.81 Million USD | 1041.02% |
2019 Q2 | 2.85 Million USD | -58.15% |
2019 Q3 | 1.58 Million USD | -44.47% |
2018 Q4 | 596.85 Thousand USD | -36.32% |
2018 FY | 3.5 Million USD | -62.02% |
2018 Q1 | 2.32 Million USD | 28.42% |
2018 Q2 | 1.49 Million USD | -35.88% |
2018 Q3 | 937.27 Thousand USD | -37.25% |
2017 Q3 | 1.97 Million USD | -29.17% |
2017 Q4 | 1.81 Million USD | -7.96% |
2017 Q2 | 2.78 Million USD | 4.85% |
2017 FY | 9.22 Million USD | 80.15% |
2017 Q1 | 2.65 Million USD | -38.28% |
2016 Q4 | 4.29 Million USD | 622.08% |
2016 FY | 5.11 Million USD | 1224.53% |
2016 Q3 | 595.41 Thousand USD | 455.14% |
2016 Q1 | 116.68 Thousand USD | 0.0% |
2016 Q2 | 107.25 Thousand USD | -8.08% |
2015 FY | 386.45 Thousand USD | 0.0% |
2015 Q2 | 51.38 Thousand USD | 0.0% |
2015 Q3 | 76.48 Thousand USD | 48.86% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Omnicell, Inc. | 534.79 Million USD | 99.491% |
Renalytix Plc | 29.04 Million USD | 90.635% |
Schrödinger, Inc. | 318.14 Million USD | 99.145% |
Simulations Plus, Inc. | 37.02 Million USD | 92.653% |
SOPHiA GENETICS SA | 117.73 Million USD | 97.69% |
Streamline Health Solutions, Inc. | 31.19 Million USD | 91.28% |
BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 99.789% |
CareCloud, Inc. | 93.35 Million USD | 97.087% |
HealthEquity, Inc. | 401.74 Million USD | 99.323% |
iCoreConnect Inc. | 15.12 Million USD | 82.017% |
Inovalon Holdings, Inc. | 427.99 Million USD | 99.365% |
Ontrak, Inc. | 29.47 Million USD | 90.773% |
Minerva Surgical, Inc. | 58.14 Million USD | 95.322% |
Nutex Health, Inc. | 66.54 Million USD | 95.913% |
OneMedNet Corporation | 8.24 Million USD | 67.019% |
Progyny, Inc. | 176.61 Million USD | 98.46% |
Augmedix, Inc. | 40.3 Million USD | 93.252% |
CareCloud, Inc. | 93.35 Million USD | 97.087% |
GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.95% |
Sharecare, Inc. | 225.97 Million USD | 98.796% |
Aclarion, Inc. | 4.87 Million USD | 44.218% |
CareMax, Inc. | 670.05 Million USD | 99.594% |
Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | 49.888% |
Forian Inc. | 20.59 Million USD | 86.797% |
Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | 49.888% |
HeartBeam, Inc. | 15.31 Million USD | 82.24% |
GeneDx Holdings Corp. | 224.28 Million USD | 98.787% |
Definitive Healthcare Corp. | 546.47 Million USD | 99.502% |
10x Genomics, Inc. | 674.94 Million USD | 99.597% |
Zhongchao Inc. | 13.92 Million USD | 80.465% |
Accolade, Inc. | 306.51 Million USD | 99.113% |
MSP Recovery, Inc. | 565.43 Million USD | 99.519% |
R1 RCM Inc. | 336.6 Million USD | 99.192% |
Spok Holdings, Inc. | 90.97 Million USD | 97.011% |
Privia Health Group, Inc. | 134.31 Million USD | 97.975% |
EUDA Health Holdings Limited | 4.8 Million USD | 43.376% |
TruBridge, Inc. | 206.17 Million USD | 98.681% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 99.789% |
Sharecare, Inc. | 225.97 Million USD | 98.796% |
Health Catalyst, Inc. | 258.73 Million USD | 98.949% |
GoodRx Holdings, Inc. | 710.34 Million USD | 99.617% |
Premier, Inc. | 683.65 Million USD | 99.602% |
HealthStream, Inc. | 168.02 Million USD | 98.381% |
Certara, Inc. | 254.08 Million USD | 98.93% |
GeneDx Holdings Corp. | 224.28 Million USD | 98.787% |
Ontrak, Inc. | 29.47 Million USD | 90.773% |
SHL Telemedicine Ltd. | 34.26 Million USD | 92.063% |
CareCloud, Inc. | 93.35 Million USD | 97.087% |
EUDA Health Holdings Limited | 4.8 Million USD | 43.376% |
HeartBeam, Inc. | 15.31 Million USD | 82.24% |
Mangoceuticals, Inc. | 9.65 Million USD | 71.817% |
CareMax, Inc. | 670.05 Million USD | 99.594% |
Healthcare Triangle, Inc. | 18.12 Million USD | 84.995% |
National Research Corporation | 52.52 Million USD | 94.822% |
Aclarion, Inc. | 4.87 Million USD | 44.218% |
OptimizeRx Corporation | 69.3 Million USD | 96.076% |